跳至主要内容
临床试验/CTRI/2023/07/054983
CTRI/2023/07/054983尚未招募Unknown

Prospective cohort study to evaluate impact of bariatric metabolic surgery(BMS)on nephropathy in 27.5-32.5 kgs/sqm body mass index type 2 diabetes patients - NI

Wockhardt Hospitals Limited, Mumbai Central0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Adult individuals 18-70 years of age
  • 2. BMI: 27.5-32.5 kg/m2 (Class 1 obesity)
  • 3. Known Type 2 Diabetes Mellitus > 1 year
  • 4. Baseline HbA1c >7% on regular medical management

排除标准

  • 1. Type 1 Diabetes Mellitus
  • 2. Latent Auto-immune Diabetes of Adults (LADA)
  • 3. Maturity Onset Diabetes of Young (MODY)
  • 4. Previously operated bariatric and metabolic surgery patients
  • 5. Patients with history of pancreatic disease or surgery
  • 6. Patient at very high risk of anesthetic complications
  • 7. Known endocrinal causes of obesity like Cushingâ??s syndrome
  • 8. Patients who lack comprehension of the bariatric surgical procedures
  • 9. Patients with known and uncontrolled psychiatric disorders like schizophrenia and major depression
  • 10. Patients with active substance/ drug abuse
  • 11. Patients unwilling to give the time commitment and consent

研究者

发起方
Wockhardt Hospitals Limited, Mumbai Central

相似试验